NPPB and hydrops fetalis: Although several valuable biomarkers such as N-terminal prohormone of brain natriuretic peptide (NT-proBNP) [4,5] and cardiac troponins [6] have been introduced for patients with HF, their use in routine clinical practice is often constrained by their cost and limited availability.